Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines

Gynecologic Oncology

Volumn 70, Issue 3, 1998, Pages 372-377

  Cagnoli, Monica ^a   Barbieri, Federica ^a   Bruzzo, Cristina ^a   Alama, Angela ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN D1;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 0032169680     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5062     Document Type: Article

References (26)

1. Motokura T, Arnold A. Cyclin and oncogenesis. Biochem Biophys Acta. 1155:1993;63-78.
2. Sherr C J. D-type cyclins. Trends Biochem Sci. 20:1995;187-190.
3. Hinds P W, Dowdy S F, Eaton E NG, Arnold A, Weinberg R A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA. 91:1994;709-713.
4. Rosenberg C L, Motokura T, Kronemberg H M, Arnold A. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene. 8:1993;519-521.
5. Bartkova J, Lukas J L, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 57:1994;353-361.
6. Schuuring E, Verhoeven E, Mooi W J, Michalides R JAM. Identification and cloning of two overexpressed genes U21B31/PRAD 1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 7:1992;355-361.
7. Motokura T, Bloom T, Kim H G, Juppner H, Ruderman J V, Kronenberg H V, Arnold H. A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature. 350:1991;512-515.
8. Withers D A, Harvey R C, Faust J B, Melnyk O, Carey K, Meeker T C. Characterization of a candidate bcl-1 gene. Mol Cell Biol. 11:1991;4846-4853.
9. Tam W, Theodoras A M, Shay J JW, Draetta G F, Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene. 9:1994;2663-2674.
10. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene. 10:1995;775-777.
11. Pines J. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci. 18:1993;195-197.
12. Hélène C. Control of oncogene expression by antisense nucleic acids. Eur J Cancer. 30A:1994;1721-1726.
13. Barbieri F, Cagnoli M, Ragni N, Pedullà F, Foglia G, Alama A. Expression of cyclin D1 correlates with malignancy in human ovarian tumours. Br J Cancer. 75:1997;1263-1268.
14. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell. 65:1991;691-699.
15. Bénard J, Da Silva J, De Blois M C, Boyer P, Duvillard P, Chiric E, Riou G. Characterization of a human ovarian adenocarcinoma line IGROV1, in tissue culture and in nude mice. Cancer Res. 45:1985;4970-4979.
16. Buckley M F, Sweeney K JE, Hamilton J A, Sini R L, Manning D L, Nicholson R I, deFazio A, Watts C KW, Musgrove E A, Sutherland R L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
17. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Advances in Cancer Research. 1996;Academic Press, San Diego. p. 67-97.
18. Piver M S, Baker T R, Piedimonte M, Sandecki A M. Epidemiology and etiology of ovarian cancer. Semin Oncol. 18:1991;177-185.
19. Narayanan R, Akhtar S. Antisense therapy. Curr Opin Oncol. 8:1996;509-515.
20. Ryte A, Morelli S, Mazzei M, Alama A, Franco P, Canti G F, Nicolin A. Oligonucleotide degradation contributes to resistance to antisense compounds. Anti-cancer Drugs. 4:1993;197-200.
21. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene. 9:1994;707-718.
22. Del Sal G, Murphy M, Ruaro E M, Lazarevic D, Levine A J, Schneider C. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene. 12:1996;177-185.
23. Baldin V, Lukas J, Marcote M J, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:1993;812-821.
24. Skotzko M, Wu L, Anderson W F, Gordon E M, Hall F. Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res. 55:1995;5493-5549.
25. Zhou P, Jiang W, Zhang Y, Kahn S M, Schieren I, Santella R M, Weinstein I B. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene. 11:1995;571-580.
26. Hung W, Huang J S, Chuang L Y. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Biochem Biophys Res Commun. 220:1996;719-723.